Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Harrison

Showing results (21-30 of 318) with videos related to

Pageof 32
Sort By:
Journal of Hepatology|November 3, 2022
NASH cirrhosis trials and major adverse liver outcomes: Big data neededMazen Noureddin, Stephen A Harrison
The New England Journal of Medicine|May 1, 2024
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. ReplyStephen A Harrison, Rebecca Taub
Alimentary Pharmacology & Therapeutics|November 21, 2023
Editorial: Liver hypercortisolism as a potential target for MASH treatmentStephen A Harrison, Julie Dubourg
Gastroenterology & Hepatology|August 31, 2012
Hepatitis C virus infection and nonalcoholic steatohepatitisAnish Patel, Stephen A Harrison
Journal of Clinical Gastroenterology|August 19, 2006
Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphataseMatthew W Pantsari, Stephen A Harrison
Current Gastroenterology Reports|February 11, 2005
Comparison of the natural history of alcoholic and nonalcoholic fatty liver diseaseShane J Mills, Stephen A Harrison
The American Journal of Gastroenterology|November 11, 2005
New advances in evaluation and management of patients with polycystic liver diseaseHays L Arnold, Stephen A Harrison
Journal of Hepatology|February 20, 2003
Hereditary hemochromatosis: update for 2003Stephen A Harrison, Bruce R Bacon
Nature Reviews. Gastroenterology & Hepatology|July 31, 2013
NAFLD: Predictive value of ALT levels for NASH and advanced fibrosisDawn M Torres, Stephen A Harrison
Gastroenterology & Hepatology|March 21, 2017
Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and TreatmentJoel Z Stengel, Stephen A Harrison
Pageof 32

Showing results (21-30 of 318) with videos related to

Sort By:
Pageof 32
Journal of Hepatology|November 3, 2022
NASH cirrhosis trials and major adverse liver outcomes: Big data neededMazen Noureddin, Stephen A Harrison
The New England Journal of Medicine|May 1, 2024
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. ReplyStephen A Harrison, Rebecca Taub
Alimentary Pharmacology & Therapeutics|November 21, 2023
Editorial: Liver hypercortisolism as a potential target for MASH treatmentStephen A Harrison, Julie Dubourg
Gastroenterology & Hepatology|August 31, 2012
Hepatitis C virus infection and nonalcoholic steatohepatitisAnish Patel, Stephen A Harrison
Journal of Clinical Gastroenterology|August 19, 2006
Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphataseMatthew W Pantsari, Stephen A Harrison
Current Gastroenterology Reports|February 11, 2005
Comparison of the natural history of alcoholic and nonalcoholic fatty liver diseaseShane J Mills, Stephen A Harrison
The American Journal of Gastroenterology|November 11, 2005
New advances in evaluation and management of patients with polycystic liver diseaseHays L Arnold, Stephen A Harrison
Journal of Hepatology|February 20, 2003
Hereditary hemochromatosis: update for 2003Stephen A Harrison, Bruce R Bacon
Nature Reviews. Gastroenterology & Hepatology|July 31, 2013
NAFLD: Predictive value of ALT levels for NASH and advanced fibrosisDawn M Torres, Stephen A Harrison
Gastroenterology & Hepatology|March 21, 2017
Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and TreatmentJoel Z Stengel, Stephen A Harrison
Pageof 32